FLS
69
-2
CMS
57
3
CHRW
51
-6
PYPL
62
2
AAP
29
-3
TDC
81
5
HIG
51
3
RSG
62
-2
RL
75
3
EQIX
60
-3
ADM
30
-3
XRAY
47
-2
ACN
45
-4
UHS
52
2
SPG
53
2
EXPD
37
-2
MAS
52
-2
MAR
62
-3
CSCO
61
-3
KR
57
-6
FLS
69
-2
CMS
57
3
CHRW
51
-6
PYPL
62
2
AAP
29
-3
TDC
81
5
HIG
51
3
RSG
62
-2
RL
75
3
EQIX
60
-3
ADM
30
-3
XRAY
47
-2
ACN
45
-4
UHS
52
2
SPG
53
2
EXPD
37
-2
MAS
52
-2
MAR
62
-3
CSCO
61
-3
KR
57
-6
Financhill
Back

NYLI Candriam U.S. Mid Cap Equity ETF Vs. NovoCure Industry Stock Comparison

Sell
46

IQSM
NYLI Candriam U.S. Mid Cap Equity ETF

Last Price:
35.02
Seasonality Move:
5.12%
Buy
75

NVCR
NovoCure

Last Price:
33.40
Seasonality Move:
-5.24%
Sell
46
NYLI Candriam U.S. Mid Cap Equity ETF (IQSM) is a Sell

Is NYLI Candriam U.S. Mid Cap Equity ETF a Buy, Sell or Hold?

  • The current NYLI Candriam U.S. Mid Cap Equity ETF [IQSM] share price is $34.66. The Score for IQSM is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • IQSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

IQSM Stock Price Chart

What is NYLI Candriam U.S. Mid Cap Equity ETF's stock price today?

  • The NYLI Candriam U.S. Mid Cap Equity ETF share price today is $34.66
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IQSM is experiencing slight buying pressure.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $33.41
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

IQSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 57.87 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.25 - 34.97) Buy
Bollinger Bands (100): (31.34 - 34.08) Buy

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.78 Buy
Relative Strength Index (14 RSI): 75.34 Buy
Chaikin Money Flow: 1118573 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.36 - 28.56) Buy
Bollinger Bands (100): (14.7 - 22.78) Buy

IQSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.93 Sell
20-day SMA: 34.67 Sell
50-day SMA: 33.78 Buy
200-day SMA: 31.79 Buy
8-day EMA: 34.84 Sell
20-day EMA: 34.62 Buy
50-day EMA: 33.9 Buy
200-day EMA: 31.91 Buy

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.6 Buy
20-day SMA: 23.68 Buy
50-day SMA: 19.33 Buy
200-day SMA: 17.9 Buy
8-day EMA: 29.53 Buy
20-day EMA: 25.45 Buy
50-day EMA: 21.38 Buy
200-day EMA: 19.88 Buy

NYLI Candriam U.S. Mid Cap Equity ETF Earnings Growth & IQSM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.

NYLI Candriam U.S. Mid Cap Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):